# data[].attributes.body
Did you know that 10% of the population are neurodivegent with this figure thought to be higher in healthcare organisations? (British Dyslexia Association 2021).

We want to support neurodivergent learners to get the most out of our training programmes.
Please speak to your Clinical Educator if you are neurodivergent to discuss how we can support your individual learning needs.

# data[].attributes.body
Useful information and guidance from the RCN

# data[].attributes.attachment_link.title
Neurodiversity Guidance | Peer Support Service | Royal College of Nursing

# data[].attributes.attachment_link.description
Guidance for neurodivergent healthcare professionals and their supporters.

# data[].attributes.attachment_link.readable_text
Oncology trials within NIHR Leeds CRF focus predominantly on novel treatments for all types of solid cancers, with a particular focus on gastro-intestinal cancers, melanoma and brain tumours.

Early phase trials of new drug treatments form a large part of the oncology research within the CRF. These trials determine the highest dose of a new drug, or combination of drugs, that patients are able to tolerate safely. Although often designed for patients with any type of cancer who have exhausted standard treatment, increasingly these trials are aimed at patients whose cancers show particular molecular characteristics. In the CRF we also run later stage trials that look at the effectiveness of new drugs in specific cancer types, particularly where these involve more complex and/or experimental treatments.

Radiotherapy remains one of the most important treatment for patients with cancer. We are developing new, more sophisticated radiotherapy techniques, able to deliver more treatment to the tumour and less to surrounding normal tissues. A second important area of interest is how to safely and effectively combine radiotherapy with new targeted therapies and immunotherapies.

The majority of our trials are in collaboration with pharmaceutical companies of all sizes, from large multinationals e.g. GlaxoSmithKline, to smaller specialist companies such as E-therapeutics, Oncolytics or Transgene. We also work with Clinical Research Organisations to deliver trials for commercial sponsors. Cancer charities, especially Cancer Research UK and Yorkshire Cancer Research, are also often involved in providing both funding and expertise.

New cancer drugs work in very complex ways and increasingly we use sophisticated laboratory molecular analysis to ensure that the drug is reaching the tumour and behaving as predicted. Interventional radiology allows biopsy of tumours before and after treatment which are then subjected to pharmaco-dynamic analyses, while molecular imaging can determine activity of new drugs without the need for a biopsy.

NIHR Leeds CRF is one of the UK's main centres carrying out trials on oncolytic viruses. These are viruses that specifically infect cancer cells, rather than normal cells, causing them to die. This can also stimulate the body's own immune system to attack cancer cells elsewhere in the body and we are able to measure these immune effects in the laboratory.

We are keen to work on novel approaches to treating patients with cancer and have particular expertise in working with cannabinoids - cannabis derivatives that have anti-cancer properties in the laboratory and are now being investigated in patients.

# data[].attributes.attachment_link.description
Oncology trials within NIHR Leeds CRF focus predominantly on novel treatments for all types of solid cancers, with a particular focus on gastro-intestinal cancers, melanoma and brain tumours. Early phase trials of new drug treatments form a large part of the oncology research within the CRF.

# data[].attributes.body
Browse the current OL prospectus to find additional training courses to support your personal and professional development needs.

# data[].attributes.attachment_link.description
Welcome to the LTHT learning prospectus for 2024/25. Our prospectus supports the Trust ambition to enable all LTHT employees, regardless of their professional background, to access high quality learn

# data[].attributes.body
The Research Academy has launched an e-Learning module for IRMER regulations.
Please follow the guide to access the training via your training interface account.

# data[].attributes.attachment_link.title
Haematology – NIHR Leeds Clinical Research Facility

# data[].attributes.attachment_link.description
Leeds is the UK’s leading centre for research into Chronic Lymphocytic Leukaemia (CLL), with early stage and complex trials into treatments for the disease carried out within our facility. Our research also looks at treatments for myeloma, Waldenström’s macroglobulinemia, low grade and aggressive ly…

# data[].attributes.body
Clinical Skills Training is offered in the following areas:

*Venepuncture
*Cannulation
*12 Lead ECG recording
* Clinical observations utilising the ABCDE assessment process and SBAR handover approach- Launch date TBC

The current 2024 training schedule is as follows:

27th February- Venepuncture

27th February- Cannulation

16th April- Venepuncture

16th April- Cannulation

16th April- 12 Lead ECG

5th June- Venepuncture

5th June- Cannulation

5th June- 12 Lead ECG

17th July- 12 Lead ECG

11th September- Venepuncture

11th September- Cannulation

8th October- 12 Lead ECG

7th November- Venepuncture

7th November- Cannulation

17th December- 12 Lead ECG

Places will be given out on a first-come, first-served basis; for more information or to reserve a space in the session(s), please contact research.academylth@nhs.net

# data[].attributes.body
ATMPs are cutting edge complex treatments and are a growing area of research in the UK.

ATMP refers to a medicinal product which is either:
1- A gene therapy
2- A somatic cell therapy
3- A tissue engineered product

# data[].attributes.headline
Cancer Researchers Introductory Course- CRIC

# data[].attributes.subject
Cancer Researchers Introductory Course- CRIC

# data[].attributes.body
The Cancer Researchers’ Introductory Course is an in house full day training course for all new staff working in the Cancer Division.
It is most beneficial for new and nearly new staff, ideally completed within the first 3 months of your new role.

The course covers:
- Key words and terminology routinely used in cancer research
- Understanding the biological basis of cancer and the link to the mechanism of action of treatments
- Exploring the common pathways for cancer patients from diagnosis and through the different treatment modalities
- Reviewing the current treatments and their adverse events
- Learning about the impact of a cancer diagnosis on a patient and their family and to consider survivorship.

Please contact your Clinical Educator to register your interest and receive the upcoming course dates.
charlotte.harland@nhs.net

# data[].attributes.body
This comprehensive series of e-learning modules will help you develop your understanding of advanced therapies, how they work and how they are produced.
They are free to access and cover a wide range of topics.

# data[].attributes.attachment_link.readable_text
This programme is in partnership with...

About the Advanced Therapy Medicinal Products programme

Advanced therapy medicinal products (ATMPs) are complex treatments requiring new ways of working, knowledge and skills for the many staff groups involved in their delivery to patients, as well as presenting urgent learning needs for the healthcare professionals who care for these patients, and for the professional development teams responsible for delivering education and training.

This series of elearning sessions is designed give the learner a basic understanding of advanced therapies, the steps involved in producing these medicines and how they function in the body. The sessions take the learner from the basics of cell and gene therapy and different modalities of treatment, through to a more in-depth look at products currently being delivered through both commissioned treatment and clinical trials. Learners will also be introduced to the unique challenges of bringing these pioneering treatments to patients, as they often present novel logistical and handling requirements.

The sessions each last approximately 30 minutes, covering the following topics:

Introduction to advanced therapy medicinal products

In vivo gene therapies

Immune effector cell therapy

Focus on CAR-T cell therapy

The logistics of ATMPs in hospitals

Advanced therapy investigational medicinal product (ATIMP) clinical trials

ISBT 128 labels for advanced therapies

Procurement of cells or tissues as starting ATMP materials

Safe use of low temperature transport vessels

More information

Across the UK, there are four centres that are working to address the unique and complex challenges of bringing pioneering advanced therapy medicinal products (ATMPs) to patients. Together the centres aim to develop robust systems for the routine delivery of ATMPs as a standard of care throughout the NHS. Three of these centres make up the Advanced Therapy Treatment Centre (ATTC) network which is coordinated by the Cell and Gene Therapy Catapult and supported by the Industrial Strategy Challenge Fund, part of the government's modern Industrial Strategy. The fund is delivered by UK Research and Innovation. These centres are:

Innovate Manchester Advanced Therapy Centre Hub (iMATCH)

Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC)

Northern Alliance Advanced Therapies Treatment Centre (NA-ATTC)

The London Advanced Therapies network is funded by Research England and brings together the London scientific community working in the field of cell and gene-based therapies.

The four centres are working together, along with the Cell and Gene Therapy Catapult, to specifically look at the training requirements for the current workforce and what needs to be put in place to support delivery of these novel treatments. Experience of delivering ATMPs is currently limited to a small number of specialist centres nationwide and there is a need for awareness-raising and knowledge-building across the wider NHS workforce.

For further information on the programmes, please see
https://www.theattcnetwork.co.uk/ http://london-advanced-therapies.org/

Resources

A training resource (slides and short videos) to introduce considerations around thawing and visual inspection of cell therapy medicinal products.
Download >

The ATMP webinar series
This series of webinars will cover many aspects of cell and gene therapies, from the basics providing an introduction to how this new technology can modify diseases though to a more in-depth look into operational aspects of delivering advanced therapies.

Logistics animation
A short animation to introduce the logistics supply chain for transporting advanced therapies, with a particular focus on cell- or tissue-based products.

Nitya's patient story
A short video giving an insight into one patient's experience of receiving CAR T cell therapy.

How to access

In order to access the Advanced Therapy Medicinal Products programme, you will need an elfh account. If you do not have one, then you can register by selecting the Register button below.
Register >
To view the Advanced Therapy Medicinal Products programme, select the View button below. If you already have an account with elfh, you will also be able to login and enrol on the programme from the View button.
View >
Not an NHS organisation?

If you are not an NHS health or care organisation and therefore do not qualify for free access elfh Hub, you may be able to access the service by creating an OpenAthens account.

To check whether or not you qualify for free access via OpenAthens, you can view the eligibility criteria and register on the ' OpenAthens ' portal.

Registering large numbers of users

If you are a HR, IT or Practice Manager and would like to register and enrol large numbers of staff within your organisation for access onto the Advanced Therapy Medicinal Productsprogramme, please contact elfh directly.

Organisations wishing to use their own LMS

For HR departments wanting to know more about gaining access to courses using an existing Learning Management System please contact elfh directly to express interest.

More information

Please select the following link for more information on how to use the elfh Hub.

elfh is a Health Education England programme in partnership with the NHS and professional bodies

© elearning for healthcare 2023

# data[].attributes.attachment_link.title
Advanced Therapy Medicinal Products - elearning for healthcare

# data[].attributes.attachment_link.description
This programme is in partnership with... Advanced therapy medicinal products (ATMPs) are complex treatments requiring new ways of working, knowledge and skills for the many staff groups involved in their delivery to patients, as well as presenting urgent learning needs for the healthcare professionals who care for these patients, and for the professional development teams responsible for delivering education and training.

# data[].attributes.body
Find out more about how the NIHR supports ATMP research

# data[].attributes.attachment_link.readable_text
What we do

What do we mean by ATMP research?

An Advanced Therapy Medicinal Product (ATMP) is defined as a medicinal product which is either:

1. a gene therapy

2. a somatic cell therapy

3. a tissue engineered product

Further information about ATMPs can be found via the Human Tissue Authority webpages.
In 2019 there were approximately 127 ATMP trials in the UK (data published by the Cell and Gene Therapy Catapult). Of these, 93 were commercially-sponsored (data published by the Alliance for Regenerative Medicine (ARM) and UK BioIndustry Association (BIA)).

Challenges delivering ATMP research

Advanced therapies have been recognised as a growing area of research within the UK for clinical trials however the challenges have been perceived as follows:

Lack of specialised training across multiple groups

Restricted access to infrastructure and lack of clarity as to the infrastructure needed

Clarifying guidance for pharmacy professionals

No single industry offering

These factors may be contributing to the low number of ATMP trials in the UK, and therefore many UK-based stakeholders are working to find solutions.

How we support ATMP research

At the NIHR, we are working to avoid duplication of effort and encourage collaboration, through our ATMP Coordinating Group, which brings stakeholders together to address challenges and discuss the logistics related to the delivery of ATMPs in the NHS for research and eventual clinical translation.

ATMP research is supported through all areas of NIHR, from funding crucial research programmes to delivery via the NIHR Infrastructure such as the Biomedical Research Centres (BRCs), Clinical Research Facilities (CRFs) and the Clinical Research Network (CRN).

This pipeline of support is exemplified through the development and delivery of gene therapy studies for patients with Cystic Fibrosis, delivery of the world's first gene therapy trial for Choroidaemia and in the successful GOSH Duchenne muscular dystrophy trial. More recently during the COVID-19 pandemic, the REALIST study was designated as Urgent Public Health research and received trial delivery support from the NIHR.

Visit our funding opportunities and Industry funding pages for further details on how your ATMP project could be supported.

Support and resources

Supporting your ATMP research

Supported by the work of the NIHR Coordinating Group, the key partners have jointly produced resources to support ATMP studies. The links below will take you to partner websites where these resources can be found.

For guidance on handling ATMPs within a pharmacy setting.

A knowledge hub for advanced therapies.

Webinar series on advanced therapy medicinal products.

A series of e-learning modules providing a basic understanding of advanced therapies, the steps involved in producing these medicines, how they function in the body. The series also covers products currently being delivered through commissioned treatment and clinical trials.

Experts

NIHR ATMP Coordinating Group

The NIHR ATMP Coordinating Group was established in 2018 after mapping the UK's capacity and capability to run studies developing ATMPs. The mapping exercise identified barriers including a lack of specialist training and restricted access to infrastructure. With multiple stakeholders wishing to address these challenges the Coordinating Group was established to avoid duplication of effort and resources, and to bring the stakeholders together to share knowledge, ideas and expertise.

Establishing the right infrastructure, training and collaborative working in the field of ATMPs is vital. This group is helping to make significant headway in making the UK a leader in ATMP research.

The group is chaired by Professor Eric Alton.

ATMP Coordinating Group Projects

Specific projects have been undertaken in Working Groups led by the Coordinating Group key partners. The projects and their leads are listed below.

If you would like more information or to become involved in any of the project areas, please contact atmp@nihr.ac.uk.

Education and Workforce Development

These projects aim to:

1. join together the workforce, education and training efforts across the UK

2. develop training and educational programmes and activities for the entire workforce impacted by ATMP studies in the forming e-learning, short courses and individual modules.

Visit the Advanced Therapy Treatment Centres website to join experts from across the UK for a free webinar series on advanced therapy medicinal products.

Lead: Professor Uta Griesenbach

Guidance development

The Pan UK ATMP Pharmacy Working group has been instrumental in developing guidance in three key areas:

1. Clinical and Operational

2. Clinical Trials

3. Governance and Regulatory

Read the guidance published by the Pan UK ATMP Pharmacy Working group on the Specialist Pharmacy Service website.

Lead: Anne Black

Developing the trial infrastructure for ATMP clinical studies

Lead: Joanna Gray

Patient and public engagement activities

This work aims to enable members of the public and patients to become more aware of, and involved in, ATMP studies.

Leads: Finn Willingham and Nick Meade.

Our key partners

The NIHR ATMP Group includes clinical leaders from across the NIHR and key UK stakeholder organisations. Find out more about the NIHR ATMP group's key partners.

If you would like more information, please contact atmp@nihr.ac.uk.

# data[].attributes.attachment_link.keywords[]
advanced therapy medicinal products
atmps
amtp

# data[].attributes.attachment_link.description
An Advanced Therapy Medicinal Product (ATMP) is defined as a medicinal product which is either: a gene therapy a somatic cell therapy a tissue engineered product Further information about ATMPs can be found via the Human Tissue Authority webpages. In 2019 there were approximately 127 ATMP trials in the UK (data published by the Cell and Gene Therapy Catapult).

# data[].attributes.body
Welcome to the Leeds Clinical Research Facility (LCRF) Padlet.

Here you will find links and suggestions for further training and development opportunities to enhance your knowledge and skills in complex and innovative clinical trial delivery.

# data[].attributes.body
There are 5 CRF's throughout LTHT collectively known as Leeds Clinical Research Facility- LCRF.

LCRF covers a wide range of disease specialities including oncology, haematology, musculoskeletal, cardiovascular, neuroscience, oral and dental health and paediatrics.

The main CRF is located at St James's University Hospital with satellite units at Leeds General Infirmary- Adult and Paediatrics, Chapel Allerton Hospital and Leeds Dental Institute.

Find out more about LCRF here.

# data[].attributes.attachment_link.readable_text
The National Institute for Health and Care Research (NIHR) Leeds Clinical Research Facility (CRF) is hosted by Leeds Teaching Hospitals Trust in collaboration with the University of Leeds.

Leeds is England's third largest city with a local population of ~760,000; the wider Leeds city region (population 2.95M) is a microcosm of the country in terms of diversity, geography and multi-morbidities. Leeds Teaching Hospitals Trust provides regional and supra-regional services for ~5.4M people and recruited 17,438 patients into NIHR portfolio clinical trials in 2019-20 (6th nationally). The University of Leeds is a top 10 UK university in terms of its research power (Research Excellence Framework, 2014), and a top 100 world-ranked university (QS world rankings). Over 80% of Leeds Teaching Hospitals Trust/University of Leeds collaborations are research rated "world leading" or "internationally excellent" (CWTS bibliometrics).

The NIHR Leeds CRF carries out high quality early stage and experimental clinical trials to help new treatments and tests reach patients more quickly. The NIHR Leeds CRF consists of the CRF Core (senior management and administrative staff) at the Research and Innovation Centre based at St James's Hospital and two CRF sites:

St James's Hospital CRF (SJUH CRF): Our largest facility delivering high quality experimental medicine research, including first-in-human trials in oncology, haematology and immunology.

Leeds General Infirmary CRF (LGI CRF): specialist focus on people with cardiovascular diseases, located within the Yorkshire Heart Centre.

Leeds Teaching Hospitals Trust has two additional CRFs that collaborate with the NIHR LCRF Core but do not currently deliver trials as part of the wider NIHR LCRF. The Leeds Children's Hospital CRF (LCH CRF) is a purpose built, age-appropriate facility supporting delivery of paediatric experimental medicine research in a comprehensive range of illnesses, from antenatal conditions through to adult variants of childhood diseases. The Dental Translational and Clinical Research Unit (DenTCRU) CRF is a purpose built, self-contained, state-of-the-art dental CRF co-located on the LGI campus (as part of the University of Leeds Dental Hospital). Finally, theChapel Allerton CRF (CAH CRF) is under construction and will open in Spring 2022 to support clinical and translational research on the CAH site including musculoskeletal and dermatology research.

Core funding for the NIHR Leeds CRF supports trial delivery at the SJUH and LGI CRFs; we also work with industry, research councils and charities to run over 100 early stage, experimental or complex clinical trials at any one time.

We provide a welcoming, professional and safe environment for patients taking part in our trials, fully supported by clinical services within Leeds Teaching Hospitals Trust including world class imaging, pathology, radiotherapy and informatics/artificial intelligence.

Patients and the wider public play a key role in our research, not only as participants, but also helping us in shaping the direction of our work and in the design of research initiated in Leeds. We have particular expertise and a strong track-record in the following areas:

Cardiovascular research: heart failure and coronary disease,
Musculoskeletal research: conditions such as arthritis and rheumatism,
Oncology research: cancers that involve solid tumour,
Haematology research: including cancers of the blood,
Oral & Dental: full range of research within oral and dental health, Paediatrics: treats a comprehensive range of illnesses including Cardiovascular disease.

Experimental medicine and translational research in Leeds includes a wide range of disease specialties, including research in paediatrics, neuroscience, diabetes and gastroenterology, with trials delivered either through the NIHR Leeds CRF sites or the other non-NIHR Leeds Teaching Hospitals Trust CRFs. Wherever possible, trials are delivered on a CRF co-located with the relevant clinical services.

We conduct trials of

Novel drugs, medicines and vaccines

Cell based and viral therapies

Innovative technologies and devices

# data[].attributes.attachment_link.description
Leeds is England's third largest city with a local population of ~760,000; the wider Leeds city region (population 2.95M) is a microcosm of the country in terms of diversity, geography and multi-morbidities. Leeds Teaching Hospitals Trust provides regional and supra-regional services for ~5.4M people and recruited 17,438 patients into NIHR portfolio clinical trials in 2019-20 (6th nationally).

# data[].attributes.body
My name is Charlotte and I am the Clinical Educator for LCRF.

I graduated from the University of Leeds in 2008 and began my nursing career at Leeds General Infirmary working in Interventional Cardiology.

During this time I developed an interest in clinical research and how it can improve patient outcomes and investigate cutting edge device technology and pharmacology.

I soon began working with the Interventional Cardiology research team on a wide ranging portfolio covering interventional, early phase, CTIMP and observational studies.

During my 11 years working in clinical research I supported and delivered a large number of high profile clinical trials working collaboratively with international sponsors and representing Leeds as a top performer in complex clinical trial delivery.

One of my main strengths was supporting and teaching new members of staff on research processes and delivery.

This passion for education led me to my current role as LCRF Clinical Educator.

I joined the Research Academy in October 2022 and support the LCRF workforce with their training and development needs.

I am committed to providing training for all which educates and empowers our staff to deliver complex and innovative clinical trials across a wide range of disease specialities at LCRF.

Please contact me @ research.academylth@nhs.net

# data[].attributes.attachment_caption
The Research and Innovation Academy Education Team 

# data[].attributes.body
Left to Right: Tracey Moment, Clinical Educator (Research), Karl Ward, Lead Nurse for Research and Innovation Education, Kinga Dwornik, RA Co-ordinator, Charlotte Harland, Clinical Educator, Leeds Clinical Research Facility and Laura Britton, Clinical Educator (Research).

# data[].attributes.headline
Advanced Therapy Treatment Centre ATTC Network

# data[].attributes.subject
Advanced Therapy Treatment Centre ATTC Network

# data[].attributes.body
The ATTC project aims to develop robust systems for the routine delivery of ATMPs as a standard of care throughout the NHS in the United Kingdom.
There are a number of webinar presentations related to advanced therapy education ranging across different specialities which are free to access on the website.

# data[].attributes.attachment_link.provider_name
ATTC Network - Advanced Therapy Treatment Centre

# data[].attributes.attachment_link.title
Home • ATTC Network - Advanced Therapy Treatment Centre

# data[].attributes.attachment_link.description
At sites across the UK, the NHS and industry are working to provide ready to use systems and solutions to accelerate adoption of advanced therapies.

# data[].attributes.body
As core CRF staff working on early phase and advanced cell therapy clinical trials you need annual ILS training to maintain your clinical skills to identify and assess the deteriorating patient and act accordingly.
Your clinical educator will organise this training for you in house at the Resuscitation Education Centre SJUH.

The ILS course covers:
- Recognising and treating the deteriorating patient using the ABCDE approach
- Identifying the causes and exploring the prevention of cardiopulmonary arrest
- Opportunities to practice technical skills including quality CPR, defibrillation- manual and AED, and simple airway manoeuvres
- Discussion and utilisation of non technical skills to facilitate team leadership and membership during cardiopulmonary arrest

To qualify for ILS training you must be a registered member of staff Band 5 and above and have been qualified for >1 year.

Please contact your Clinical Educator to book on the course
charlotte.harland@nhs.net

# data[].attributes.attachment_link.readable_text
If you are a healthcare professional who would be expected to apply the skills taught as part of your clinical duties, or to teach them on a regular basis, you are eligible to participate on the ALS course. Appropriate applicants include doctors, nurses working in critical care areas (e.g. ED, CCU, ICU, HDU, operating theatres, acute medical admissions units), paramedics, ICU outreach teams or in the resuscitation/medical emergency team.

All applicants must hold a current clinical appointment and professional healthcare qualification or be in training for a professional healthcare qualification.

Medical students, student nurses and other healthcare providers not covered in the groups above should be encouraged to complete the Immediate Life Support [ILS] course. Those with a particular interest in resuscitation should then consider attending an ALS provider course, where appropriate. Medical students in their final year of training can be accepted as candidates on an ALS course if this is an established local arrangement
Advanced Resuscitation of Newborn Infant [ARNI] course:
You are eligible for the ARNI course if you hold a current RCUK Newborn Life Support provider certificate and are involved in care of the pre-term and sick newborn infants in a role more advanced than that of first responder. Candidates include specialist medical staff (ST3 level and above or about to commence a 2nd tier role), neonatal nurses with a qualification in the specialty or Advanced Neonatal Nurse Practitioners. You may also be eligible for the ARNI course if you are an experienced paramedic working extensively with newborn transfer teams, a resuscitation officer with a significant regular newborn workload or an anaesthetist with a newborn or PICU practice.
European Paediatric Advanced Life Support [EPALS] course:
If you are a healthcare professional who would be expected to apply the skills taught as part of your clinical duties, or to teach them on a regular basis, you are eligible to undertake this course. Eligible participants include doctors, nurses or paramedics working in direct contact with children.

All applicants must hold a current clinical appointment and professional healthcare qualification or be in training for a professional healthcare qualification. Medical students, student nurses in their final year of training and other healthcare providers not covered in the groups above should be encouraged to complete the Paediatric Immediate Life Support [PILS] course. Those with a particular interest in the management of acute deterioration and resuscitation in children should then consider attending an EPALS provider course, where appropriate.

Medical students in their final year of training can be accepted as candidates on an EPALS course if this is an established local arrangement.
Focused Echocardiophay in Emergency Life Support [FEEL] course:
The FEEL course is intended for healthcare professionals who are involved in the care of the critically ill patient and does not require any previous echocardiography or ultrasound experience. FEEL is intended as an adjunct to the Advanced Life Support course and as such knowledge of the current ALS algorithm is required.
Generic Instructor Course [GIC]:
To attend a GIC course you must be recommend as having 'Instructor Potential' either on an RC (UK) course or one of the Advanced Life Support Group [ALSG] recognised courses e.g. APLS. Please follow the RC (UK) GIC link for further information.
Immediate Life Support [ILS] course:
If you are a doctor, medical student, nurse, nursing student, midwife, ODP, cardiac technician, resuscitation officer, healthcare provider (such as a physiotherapist, radiographer, occupational therapist), dental nurse, dentist, paramedic/ ambulance technician, healthcare assistant or nursing associates are eligible for this course. It may also be suitable for you if you are a fire service technician, police personnel prison officer or cabin crew.
Paediatric Immediate Life Support [PILS] course:
You are eligible to undergo the pILS course if you are a doctor, nurse, health visitor, school nurse, midwife, ODP, cardiac technician, resuscitation officer, medical student (final year), nursing student (final year), physiotherapist, dentist, dental nurse, ambulance technician/paramedic, healthcare assistant or nursing associate, occupational therapist, radiographer, fire service technician, police officer or cabin crew. The pILS course addresses the needs of staff who need more advanced skills than those taught during Basic Life Support [BLS], but who do not require the more comprehensive two-day European Paediatric Advanced Life Support [EPALS] course.
Newborn Life Support [NLS] course:
You are eligible for the NLS course if you are a healthcare professional who is regularly involved in the delivery and care of the newborn infant. This includes both junior and senior medical and nursing staff, midwives, paramedics and resuscitation officers. All applicants must hold a professional healthcare qualification or be in training for a professional healthcare qualification.

# data[].attributes.attachment_link.description
If you are a healthcare professional who would be expected to apply the skills taught as part of your clinical duties, or to teach them on a regular basis, you are eligible to participate on the ALS course. Appropriate applicants include doctors, nurses working in critical care areas (e.g.

# data[].attributes.body
The United Kingdom Oncology Society- UKONS is a free to join network for all cancer nurses in the UK.
Follow the link to become a member and find out more.
UKONS - Home

# data[].attributes.body
Simulation training is a technique to recreate real world scenarios in a safe, artificial learning environment.

LCRF operates within the UKCRF Emergency Scenario Guidance where emergency scenario simulation training is a requirement for all staff working within the CRF.

We deliver emergency scenario simulation training at LCRF that is tailored to the clinical speciality and staff involved. This allows us to simulate clinically significant medical emergencies and test the protocols and pathways in place to treat and respond to the situation, such as emergency unblinding, infusion reactions, sepsis and acute escalation to high dependency level care.

This level of training ensures staff are competent and confident to deal with medical emergencies with the ultimate aim of increasing the safety of participants in clinical trials.
Through simulation, staff are able to practice critical thinking skills, patient assessment, decision making and effective team communication.

We follow a structured debriefing process which is guided by our learners and allows staff time to reflect and dissect the scenario to support a deeper level of learning and understanding.

Our emergency scenario simulation training programme is delivered in collaboration with the medical education team and resuscitation and outreach services.

# data[].attributes.body
Register with DLS to access training for PPM1, PPM+, ChemoCare, eMeds, eObs and ICE order comms requesting

# data[].attributes.attachment_link.readable_text
Cookies on Digital Learning Solutions

We've put some small files called cookies on your device to make our site work.

We'd also like to use analytics cookies. These send anonymous information about how our site is used to a service called Google Analytics & Hotjar Analytics. We use this information to improve our site.

Let us know if this is OK. We'll use a cookie to save your choice. You can read more about our cookies before you choose.

Skip to main content

Need help getting started with nursing passports on DLS? Visit our dedicated support page (opens a new tab)

Our products and services can help you manage digital learning delivery for the benefit of the people in your organisation.

# data[].attributes.attachment_link.description
We've put some small files called cookies on your device to make our site work. We'd also like to use analytics cookies. These send anonymous information about how our site is used to a service called Google Analytics & Hotjar Analytics. We use this information to improve our site.

# data[].attributes.body
Urinalysis- Louise Wray, Jena English and Claire Flanagan

Blood glucose monitoring- Sam Charlton, Jena English and Claire Flanagan

Blood transfusion- Harriet Massey

# data[].attributes.body
Anne Marie Kenny
Amanda Callister

# data[].attributes.body
Please use this template to create and maintain your own individual training record which should be reviewed annually with your line manager.

# data[].attributes.body
Please use this template to create your own research CV which should be stored in your individual training record and relevant study site files.

# data[].attributes.body
Research Funding Opportunities

New funding opportunities are open for colleagues to submit applications. The Trust’s Research and Innovation department can support you from the initial stages of the conception of a research idea to obtaining funding. There are different funding bodies, research councils, organisations and charities that launch a variety of different funding calls to support different aspects of the research cycle.
To find out more and access support with accessing funding opportunities, contact the team on leedsth-tr.researchfundingopps@nhs.net or visit Research Funding Opportunities on the Trust website.

# data[].attributes.body
Find out more about our Musculoskeletal trial programme at LCRF Chapel Allerton.

# data[].attributes.attachment_link.readable_text
Musculoskeletal (MSK) conditions are the single most common cause of chronic disability, placing a huge burden on patients and society. Significant advances in the development of innovative treatments, including biologic therapies, have changed the opportunities available to patients. Our goal is to enable the right therapy to be delivered to the right patient at the right time, and thus improve patient outcomes further.

Clinical trials at our facility are helping to evaluate new therapies to treat MSK and autoimmune diseases more effectively, and - through collaboration with the Leeds MIC contributing to our ability to detect disease early so that, in the future, we can intervene with therapies to prevent progression as well.

The MSK trial programme at NIHR Leeds CRF builds on world-leading experimental translational research at the NIHR Leeds Biomedical Research Centre (BRC) and the Leeds Institute of Rheumatic and Musculoskeletal Medicine.

Research at NIHR Leeds BRC focuses on the identification and development of biomarkers through the accurate characterisation of disease using, in particular, strengths in novel imaging. NIHR Leeds BRC pioneered the use of joint ultrasound, enabling earlier diagnosis and confirmation of disease remission and uses magnetic resonance Imaging (MRI) to understand the pathophysiology of disease and effectiveness of therapies. NIHR Leeds BRC are also developing the use of optical coherence tomography (OCT), as a first quantitative imaging skin biomarker in conditions such as scleroderma and psoriasis.

Our Facility draws on expertise within NIHR Leeds BRC, particularly the use of novel imaging techniques, to deliver early phase and complex later stage clinical trials across the full range of MSK and autoimmune conditions. This includes conditions which affect the joints, such as osteoarthritis, inflammatory arthritis (including rheumatoid arthritis and spondyloarthritis), auto-immune multisystem conditions such as lupus, vasculitis, scleroderma and inflammatory skin disorders such as psoriasis and lupus.

We have developed strong links with the leading pharmaceutical companies, including Abbvie, Bristol-Myers Squibb, Pfizer Ltd, Roche, AstraZeneca and GlaxoSmithKline, working with them on early stage commercial and academic trials to test new drug treatments.

We also receive generous support from charities such as Versus Arthritis, Lupus UK and a local ACORN charity and are successful in gaining NIHR research funding.

Our research focus is early intervention and accurate phenotyping of disease, with significant emphasis on the development of clinical, imaging and blood/tissue cellular biomarkers in order to enable more effective prognostic and treatment decisions.

MSK and autoimmune diseases are also associated with increased cardiovascular health problems. We work closely with colleagues in cardiovascular medicine to understand this increased risk - conducting trials to, for example, understand how inflammation can also contribute to cardiovascular disease - and to assess what therapies might be most effective.

# data[].attributes.attachment_link.description
Musculoskeletal (MSK) conditions are the single most common cause of chronic disability, placing a huge burden on patients and society. Significant advances in the development of innovative treatments, including biologic therapies, have changed the opportunities available to patients.

# data[].attributes.attachment_link.readable_text
The NIHR Leeds Biomedical Research Centre opened in 2008, and is an international centre of excellence which exists to provide infrastructure to support translational research across: Musculoskeletal disease, cardiometabolic disease, surgical technologies, haematology, pathology and antimicrobial resistance.

The NIHR Leeds BRC is hosted at Leeds Teaching Hospitals Trust in partnership with the University of Leeds and the University of York.

# data[].attributes.attachment_link.description
The Leeds NIHR Biomedical Research Centre is a leading centre of excellence in MSK research. It exists to provide infrastructure to support translational research across musculoskeletal disease.

# data[].attributes.attachment_link.readable_text
Cardiovascular trials at the NIHR Leeds CRF are aimed at finding new ways to diagnose, treat - and even prevent - coronary artery disease, heart disease and heart failure.

Between 30-40% of our trials are run in collaboration with pharmaceutical and medical device companies, both large and small. Recent partners include Boston Scientific, Medtronic and Abbott Vascular.

The rest of our work is primarily funded through the National Institute for Health and Care Research (NIHR), Medical Research Council (MRC) and through medical charities such as the British Heart Foundation (BHF).

Our portfolio includes early phase trials of new drug treatments for cardiovascular disease, assessing safety and tolerable doses, but we do much more than that. Much of our work also involves looking at complex experimental procedures or techniques as part of later stage clinical trials.

Because of the nature of treatments for cardiovascular diseases, many of our trials involve surgical intervention. We trial new surgical techniques, such as the use of keyhole surgery in cardiovascular operations such as valve repair/replacement, or new devices, such as defibrillators, complex pacemakers or coronary stents.

We also look at the innovative use of new or known drugs within surgical procedures, such as injection directly into the artery during an operation or even during a heart attack, to identify if this can improve the outcome or reduce damage to the heart. Other trials include investigating the safety and efficacy of administering stem cells or new drugs directly into the heart, to aid repair or improve function.

Other areas of our work involve trialling new imaging techniques, such as the latest cardiac MRI techniques, for use in improving diagnosis and risk stratification. We also conduct trials of preventative medicines, to identify if certain drugs can reduce the risk of developing cardiovascular disease in certain sections of the population.

Our state-of-the-art imaging equipment, including MRI, CT and ultrasound, alongside our specialist physiology suite, enables us to accurately assess the impact of new treatments, devices or techniques, both in terms of heart function, exercise capacity and quality of life.

# data[].attributes.attachment_link.title
Cardiovascular – NIHR Leeds Clinical Research Facility

# data[].attributes.attachment_link.description
Cardiovascular trials at the NIHR Leeds CRF are aimed at finding new ways to diagnose, treat – and even prevent – coronary artery disease, heart disease and heart failure.

# data[].attributes.attachment_link.readable_text
Oral and dental health is the newest disease area within the CRF's research portfolio. Trials take place in a state-of-the-art dedicated dental research clinic within the £1.7 million Dental Translational and Clinical Research Unit (DenTCRU) co-funded by the Wellcome Trust and the University of Leeds.

We run a mix of commercially and government funded studies including funding from the National Institute for Health and care Research for clinical trials. Our research is also supported by a number of charities, including the Oral and Dental Research Trust and the Dunhill Medical Trust.

Our studies cover the full range of research within oral and dental health, testing drug treatments, medical devices, novel dental materials and surgical procedures. We are embracing innovations in digital dentistry, drawing on the latest scanning and digital techniques to create 3D digital dental archives for use in both diagnostics, treatment planning and restoring function. This includes 3D printing of high quality dental models for faster "dignity denture" production.

DenTCRU CRF supports collection of materials for the Skeletal Tissues Research Bank that supports research to understand the mechanisms of tooth decay, erosion, wear; developing a source of stem cell for tissue regeneration and development of new dental materials that in turn will be evaluated in the DenTCRU CRF.

DenTCRU CRF successfully undertook the first-in-man trials on self-assembling peptides (SAP) based on Professor Jennifer Kirkham's research carried out at the University of Leeds. The product 'Curadont Repair', using this peptide technology, gained CE mark approval for clinical use and is now on the market for use in stimulating repair in teeth showing early signs of decay. We are also working on new atraumatic restorative therapy to assess a novel approach for the prevention of root caries in the elderly.

Next generation sequencing within our laboratory facilities allows us to run studies that involve complex analysis of the oral microbiome - the bacteria within the mouth and how these interact. We are developing trials looking at the use of improved stewardship of antimicrobials with a particular focus on addressing antimicrobial resistance.

We also work on studies which require genetic profiling of patients, such as identifying genetic markers for inherited enamel developmental disorders including Amelogenesis Imperfecta.

Changes in our oral health can provide early signs of systemic disorders, and we are collaborating with Musculoskeletal researchers within NIHR Leeds CRF to identify if gingivitis - inflammation of the gums - is an early marker for rheumatoid arthritis

# data[].attributes.attachment_link.description
Oral and dental health is the newest disease area within the CRF's research portfolio. Trials take place in a state-of-the-art dedicated dental research clinic within the £1.7 million Dental Translational and Clinical Research Unit (DenTCRU) co-funded by the Wellcome Trust and the University of Leeds.

# data[].attributes.attachment_link.description
Welcome to the Children's Clinical Research Team Research is a priority in the Leeds Children's Hospital, and we aim to allow families the opportunity to take part in a wide variety of quality research, contributing to local, national and international studies.

# data[].attributes.body
Refresh your knowledge of the ABCDE Assessment Approach

# data[].attributes.attachment_link.description
Information about using the Airway, Breathing, Circulation, Disability, Exposure (ABCDE) approach to assess and treat patients.

# data[].attributes.body
Refresher training is intended for any practitioner who will soon use a clinical skill and:

·        Previously attended the clinical skill session at LTHT and has been signed off as competent to practice but has not practiced a skill for 6-12 months or more.

·        Previously attended the clinical skill session at a hospital trust other than LTHT and has been signed off as competent to practice.

LCRF Staff

If this applies to you, please contact your Clinical Educator charlotte.harland@nhs.net who can organise a refresher training session and competency sign off update with you so you can return to independent practice of clinical skills.

Research delivery staff

If this applies to you, please contact research.academylth@nhs.net to organise refresher training.

# data[].attributes.body
Do you have a keen interest in education and training and would like to become the education champion for your CRF?
We are looking for individuals who can act as a training an education link between the CRF Clinical Educator, Research Academy and the clinical CRF teams.
This would involve helping your educators to share and disseminate information with your CRF teams, and meeting quarterly to share education updates and discuss any training needs for your CRF.
Please email charlotte.harland@nhs.net to register your interest in this role.

# data[].attributes.headline
IV medicines administration and pump training

# data[].attributes.subject
IV medicines administration and pump training

# data[].attributes.body
If you need full IV or refresher training please contact the MMPS Nursing team to book intravenous medicine theory and pump training.
leedsth-tr.mmpsnursing.net

# data[].attributes.body
If you need training to access Central Venous Access Devices (CVADs) please contact the Senior Chemotherapy Nurses

Anne-marie Kenny

Amanda Callister

# data[].attributes.attachment_link.title
Haematology and BMT: Understanding Treatment, Management and Care

# data[].attributes.attachment_link.description
Apply for Haematology and BMT: Understanding Treatment, Management and Care at the University of Bradford.

# data[].attributes.attachment_link.description
NIHR Associate Principal Investigator Scheme Resources site

# data[].attributes.body
Scroll down to the section on Blood Culture Pathway awareness and watch the two videos on:
Improving the blood culture pathway
Blood culture pathway: Taking a blood culture

# data[].attributes.attachment_link.readable_text
This programme is in partnership with...

About the Antimicrobial Resistance and Infections programme

The Antimicrobial Resistance (AMR) and Infections programme has been designed to support health and care staff - both clinical and non-clinical - in a variety of settings to understand the threats posed by antimicrobial resistance, and the ways they can help to tackle this major health issue. This programme has been developed by Health Education England (HEE) in collaboration with Public Health England (PHE), NHS England and NHS Improvement, Care Quality Commission and National Institute for Health and Care Excellence.

Antibiotic (antimicrobial) resistance poses a major threat to everyday life and modern day medicine where lives could be lost as a result of antibiotics not working as they should. All health and care staff, as well as the public, have a very important role in preserving the power of antibiotics and in controlling and preventing the spread of infections. Amongst the approaches to reduce this threat includes adequate infection prevention and control practices, good antimicrobial stewardship and the use of diagnostics.

Visit HEE website for more information on our AMR work.

AMR toolkit

HEE has produced an AMR toolkit , making available credible and helpful resources relating to antimicrobial resistance, as well as learning about the management of infective states, infection prevention and control and antimicrobial stewardship.

eLearning

Antimicrobial Prescribing for Urinary Tract Infections (UTIs)

The Antimicrobial Prescribing for Urinary Tract Infections (UTIs) elearning provides a quick overview on the key points to consider when prescribing antibiotics for UTIs, as outlined in the NICE guidance on managing common infections.

The session covers why the management of UTIs matter, what you need to know as a clinician, what you can do in your clinical practice and where can you find more information.

This bite-sized session is accompanied by an assessment and learners have the flexibility of assessing their knowledge before and/or after engaging with the session.

The AMR toolkit can support you in addressing any further learning needs you identify through completing this elearning.

Introduction to Antimicrobial Resistance

The Introduction to Antimicrobial Resistance session supports health and care staff, including non-clinical staff working for independent contractors within the NHS, as well as volunteers across health and care settings and service provision:

discuss why there is such a concern about misuse of antibiotics and antimicrobial resistance.

list the key risks for development of antimicrobial resistance.

identify their role in tackling antimicrobial resistance.

It provides an overview for clinical and non-clinical staff. It will also be of benefit to all health and care staff, including those non-clinical staff working for independent contractors within the NHS, as well as volunteers across health and care settings and service provision.

Antibiotic Review kit - (ARK)

ARK is an antimicrobial stewardship initiative that aims to safely reduce antibiotic use in hospitals by helping staff stop unnecessary antibiotic treatments. This protects patients from drug side-effects like Clostridium difficile and antibiotic resistant infections.

This elearning was developed in partnership with British Society of Antimicrobial Chemotherapy (BSAC) and covers the rationale for the Antibiotic Review Kit, presents the ARK Decision Aid and also includes some brief scenarios, with reflection questions to consolidate learning.

Antimicrobial Stewardship for Community Pharmacy staff

How Community Pharmacies Can Keep Antibiotics Working

This free elearning session addresses the impact of antimicrobial resistance and the hugely important role community pharmacy staff can play in it.

This elearning will help community pharmacy staff:

understand the connection between antibiotic use and antibiotic resistance

identify their role in optimising antibiotic use in the general population who visit their pharmacy

use the Antibiotic Checklist to personalise patient advice when dispensing antibiotics

improve their self-care/safety-netting advice using the Treat Antibiotics Responsibly, Guidance, Education, Tools (TARGET) Treating Your Infection leaflets

be aware of the global impact of antibiotic resistance

This has been developed by Public Health England in partnership with British Society of Antimicrobial Chemotherapy (BSAC), Royal Pharmaceutical Society, University of Leeds, University of Nottingham. Graphic design provided by The Letter G.

Case studies

Antimicrobial Stewardship for Pharmacy Staff - case study

The Royal Pharmaceutical Society supported key pharmacists within NHS Trusts and Sustainability and Transformation Partnerships (STPs) to develop the skills and behaviours to become effective antimicrobial clinicians, leaders and mentors via a pilot training programme in London and the south east of England.

You can view the individual case studies from the training here.

Action on AMR - case study

Action on AMR focussed on equipping teams with QI skills to deliver their improvement work and share successful initiatives, rather than demonstrating a significant reduction in Gram-negative bloodstream infections (GNBSI) rates in the region. It is hoped that infection rates will be reduced in future as the teams progress their improvement work using the skills and knowledge gained.

Antimicrobial Stewardship (AMS) change - case study

The University of Manchester - AMS change project developed a cohort of "AMS CHANGErs": experts in behaviour change related to AMS, with the capability, opportunity and motivation to drive change in health professional practices related to AMS.

The following report - AMS Change: Practical training to apply behavioural science to antimicrobial stewardship , outlines the development and training that has been created. It can support the development of AMS Change projects in local areas.

Films

AMR Public Awareness

AMR Public Awareness

This short animation is aimed at the public and has been produced in partnership with PHE, intended to be used by health and social care staff in a variety of settings with the aim of helping prescribers respond appropriately to patients requesting antibiotics without medical need. The creation of the animation was influenced by the work of the Wellcome Trust in understanding how the public responds to information about antimicrobial resistance.

AMR GP and Primary Care Awareness

AMR GP and Primary Care Awareness

Also developed is an introductory film entitled a guide for GPs on antimicrobial resistance aimed at GPs and primary care staff to provide an introduction into the risks associated with the over-use of antibiotics, and to encourage appropriate dispersion of the animation above. It supports a range of educational materials for GPs and other primary care prescribers called the TARGET toolkit.

Urinary Tract Infection Management in the Elderly

Urinary Tract Infection Management in the Elderly

Surveillance shows that previous urinary tract (bladder) infections, urinary catheterisation, hospitalisation, being prescribed antibiotics in the previous month and old age are key risk factors for these infections in the out of hospital setting. This short film aims to support health and care workers looking after older adults with suspected urinary tract infections (UTIs) and introduces resources that can be used to diagnose, manage and prevent UTIs in the out of hospital setting. In particular Public Health England's (PHE) diagnostic flowchart and a patient leaflet to facilitate the management of suspected UTIs in the older frail population.
'To Dip Or Not To Dip' has a network of health and social care professionals who are improving the management of UTI in older people in care settings throughout the UK. To join this community email elizabeth.beech@nhs.net

Blood Culture Pathway Awareness

We collaborated with NHS England and NHS Improvement to produce 2 animated videos to improve antimicrobial stewardship by raising awareness and promoting an optimal blood culture pathway as set out by Public Health England.

The first animation is a general overview, designed to raise awareness of the issues and will explain the background of AMR, the importance of an optimal blood culture pathway in AMS, and some of the factors to consider in the pre-analytical, analytical and post-analytical phases.

The second animation is a step-by-step guide of good practice in taking a blood culture sample in the pre-analytical phase.

Improving the blood culture pathway

Blood culture pathway: Taking a blood culture

Primary Care Antibiotic Prescribing

This film is aimed at health and care staff who recommend, prescribe, dispense and supply antibiotics in primary care. It highlights processes, considerations and actions that should occur to support safe and effective antibiotic prescribing and signposts to further available resources. The film is based on the TARGET Toolkit and NICE Guidance on 'Managing common infections and antimicrobial stewardship'.

This will help health and care staff to:

understand the connection between antibiotic use and antibiotic resistance.

identify their role in optimising antibiotic use and stewardship.

ensure compliance with national guidance when recommending, prescribing, dispensing and administering antibiotics.

improve their self-care/safety-netting advice to patients on the appropriate use of antibiotics.

Secondary Care Antibiotic Prescribing

This film is aimed at health and care staff who recommend, prescribe, dispense and supply antibiotics in secondary care. It highlights processes, considerations and actions that should occur to support safe and effective antibiotic prescribing and signposts to further available resources. The film is based on Public Health England's 'Start Smart - Then Focus: Antimicrobial Stewardship Toolkit' and NICE Guidance on antimicrobial stewardship.

This will help health and care staff to:

understand the connection between antibiotic use and antibiotic resistance.

identify their role in optimising antibiotic use and stewardship.

ensure compliance with national guidance when recommending, prescribing, dispensing and administering antibiotics.

improve their self-care/safety-netting advice to patients on the appropriate use of antibiotics.

Further information

For more information on HEE's work on antimicrobial resistance, please visit our website.

Antimicrobial prescribing for common infections elearning session

How to access

Available to all

The Antimicrobial Resistance and Infectionsprogramme is freely available to access here.
Please note your progress and completion of sessions will not be recorded and you will not be able to generate a record of completion. If you require evidence of learning, please register and then log in to access this programme on the elfh Hub.

If you already have an account with elfh, then you can enrol on to the Antimicrobial Resistance and Infections programme by logging in to the elfh Hub, selecting My Account > Enrolment and selecting the programme. You can then access the programme immediately in the My elearning section.

In order to access the Antimicrobial Resistance and Infections programme, you will need an elfh account. If you do not have one, then you can register by selecting the Register button below.
Register >
To view the Antimicrobial Resistance and Infections programme, select the View button below. If you already have an account with elfh, you will also be able to login and enrol on the programme from the View button.
View >
NHS healthcare staff in England

The Antimicrobial Resistance and Infections programme is also available to NHS healthcare staff via the Electronic Staff Record (ESR). Accessing this elearning via ESR means that your completions will transfer with you throughout your NHS career.

Further details are available here.

Not an NHS organisation?

If you are not an NHS health or care organisation and therefore do not qualify for free access elfh Hub, you may be able to access the service by creating an OpenAthens account.

To check whether or not you qualify for free access via OpenAthens, you can view the eligibility criteria and register on the ' OpenAthens ' portal.

Registering large numbers of users

If you are a HR, IT or Practice Manager and would like to register and enrol large numbers of staff within your organisation for access onto the Antimicrobial Resistance and Infectionsprogramme, please contact elfh directly.

Organisations wishing to use their own LMS

For HR departments wanting to know more about gaining access to courses using an existing Learning Management System please contact elfh directly to express interest.

Access for care home or hospice staff

To register for the Antimicrobial Resistance and Infections programme, select the 'Register' button above. Select the option 'I am a care home or hospice worker' then enter your care home / hospice name or postcode and select it from the options available in the drop down list. Finally enter your care home / hospice registration code and select 'Register'. You may need to see your employer to get this code.

If your employer does not have a code, then they need to contact the elfh Support Team. The Support Team can either give the employer the Registration Code or arrange a bulk upload of all staff.

Access for social care professionals

Access to elfh content is available to all social care professionals in England whose employers are registered with the Skills for Care National Minimum Data Set for Social Care (NMDS-SC). Every employer providing NMDS-SC workforce information to Skills for Care has been given a user registration code for their staff. This code enables you to self-register for access to the Antimicrobial Resistance and Infections programme. Please contact your employer for more details about the registration code. For information about registering your organisation with the NMDS-SC your employer should access www.nmds-sc-online.org.uk or contact the Skills for Care Support Service on 0845 8730129.
If you have a registration code select the 'register' button above.
More information
Please select the following link for more information on how to use the elfh Hub.

© elearning for healthcare 2023

# data[].attributes.attachment_link.title
Antimicrobial Resistance and Infections - elearning for healthcare

# data[].attributes.attachment_link.description
This programme is in partnership with... The Antimicrobial Resistance (AMR) and Infections programme has been designed to support health and care staff - both clinical and non-clinical - in a variety of settings to understand the threats posed by antimicrobial resistance, and the ways they can help to tackle this major health issue.

# data[].attributes.body
The NHS and British Society for Antimicrobial Chemotherapy have collaborated and produced a comprehensive package of e-Learning which explores the role you play in optimising the blood culture pathway.
There are separate modules for:

Neonate and paediatric staff

Patient facing staff

Laboratory staff

Consultant microbiologists

# data[].attributes.attachment_link.title
Blood Culture Pathway Modules - Infection Learning Hub

# data[].attributes.attachment_link.description
These modules has been developed by NHS colleagues in collaboration with BSAC. They explore the role you play ...

# data[].attributes.body
UKONS are really pleased to announce that the Level 1 Acute Oncology e-learning with competence passport is now live on the Macmillan learning hub. This online resource has been developed as part of the National AO Passport Project with UKONS and the UK Acute Oncology Society (UKAOS) together with the CASCADE research study team (Co-design of Acute oncology Standardised Competence Assessment Documents and their Evaluation).

The UK Acute Oncology Competence Assessment Passports aim to promote the development of a knowledgeable, skilled, and competent workforce that treats and cares for people with an acute oncology indication. The Passports cover four levels of Acute Oncology knowledge and skills competence, aligning with the UKONS Acute Oncology Knowledge and Skills Guidance. These levels are-:

Level 1 (Core)

Level 2 (Intermediate)

Level 3 (Advanced)

Level 4 (Expert)

# data[].attributes.attachment_link.title
Education and Training | Healthcare professionals

# data[].attributes.attachment_link.description
We offer online courses, conferences and webinars to give health and social care professionals the training they need to support people living with cancer.

# data[].attributes.body
The Research Academy offers an extensive programme of training and education courses with the aim of promoting excellence in clinical research delivery.

Follow the link to the Research Academy Padlet to discover what research specific training we offer and how to book.

# data[].attributes.attachment_link.title
Advanced Therapies at the NIHR Leeds Clinical Research Facility (CRF) - NIHR Leeds Clinical Research Facility

# data[].attributes.attachment_link.description
The NIHR Leeds Clinical Research Facility is helping to shape the future of healthcare. In this blog post, Prof Chris Twelves, Clinical Director at the CRF, outlines what advanced therapies are, why they matter, and how the CRF is supporting their safe and effective development for patients.